Flexion Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

Flexion Therapeutics, Inc. (Nasdaq: FLXN) announced that its CEO, Michael Clayman, M.D., will participate in a virtual fireside chat at the BMO 2020 Prescriptions for Success Healthcare Conference.

Rhea-AI Summary

Flexion Therapeutics, Inc. (Nasdaq: FLXN) announced that its CEO, Michael Clayman, M.D., will participate in a virtual fireside chat at the BMO 2020 Prescriptions for Success Healthcare Conference. The event is scheduled for June 23, 2020, starting at 9:30 a.m. ET. Interested parties can access the live webcast on Flexion's website. Flexion Therapeutics focuses on creating innovative local therapies for musculoskeletal conditions, particularly targeting osteoarthritis.

News Market Reaction – FLXN

+1.18%

+1.18% Session move

In the trading session that priced this news, FLXN gained 1.18%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., June 16, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the BMO 2020 Prescriptions for Success Healthcare Conference. The virtual fireside chat is scheduled to begin at 9:30 a.m. ET on Tuesday, June 23, 2020.

To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.

About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. Visit flexiontherapeutics.com.

Contact:

Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com

 

FAQ

What is the date of the analyst-led fireside chat for Flexion Therapeutics?

The fireside chat is scheduled for June 23, 2020.

Who will represent Flexion Therapeutics in the BMO 2020 conference?

Michael Clayman, M.D., the CEO of Flexion Therapeutics, will participate.

How can I access the Flexion Therapeutics webcast?

You can access the live webcast on Flexion's website at the time of the event.

What is Flexion Therapeutics' focus in the biopharmaceutical industry?

Flexion Therapeutics is focused on developing local therapies for musculoskeletal conditions, especially osteoarthritis.

What time will the Flexion Therapeutics fireside chat start?

The fireside chat will begin at 9:30 a.m. ET.